Financial Year |
March 31 2023 |
Monetary Funds |
231,526,195.97 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
62,662,496.32 |
Accounts Receivable |
913,598,080.51 |
Advances to Suppliers |
55,424,492.13 |
Other Receivables |
32,832,941.16 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
381,627,508.46 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
18,314,207.57 |
Other Current Assets |
17,496,807.16 |
Total Current Assets |
1,769,763,520.45 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
47,800,814.82 |
Long-term Equity Investment |
20,909,106.70 |
Investment Properties |
56,443,617.19 |
Fixed Assetes |
431,170,237.99 |
Under-construction Projects |
7,209,262.40 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
94,380,593.37 |
R&D expenses |
-- |
Goodwill |
123,934,031.28 |
Long-Term Deferred and Prepaid Expenses |
2,745,367.74 |
Deferred Income Tax Assets |
44,934,192.42 |
Other Non-Current Assets |
42,351,616.27 |
Sub-Total of Non-Current Assets |
882,838,644.25 |
Total Assets |
2,652,602,164.70 |
Short-Term Loans |
177,356,646.41 |
Trading Financial liabilities |
-- |
Notes Payable |
25,500,080.55 |
Accounts Payable |
546,985,922.92 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
20,059,639.11 |
Taxes Payable |
16,126,882.92 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
31,416,236.33 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
99,157,943.93 |
Other Current Liabilities |
44,105,851.89 |
Sub-Total of Current Liabilities |
1,164,604,566.74 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
11,344,681.09 |
Deferred Income Tax Liabilities |
7,995,745.00 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
34,977,156.07 |
Total Liabilities |
1,199,581,722.81 |
Paid-In Capital(Or Share Stock) |
427,244,052.00 |
Capital Surplus |
1,324,029,864.68 |
Surplus Reserve |
54,679,079.11 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-482,939,660.29 |
Minority Stockholder's Interest |
125,539,880.21 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,327,480,561.68 |
Owner's Equity(Stockholder's Equity) |
1,453,020,441.89 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,652,602,164.70 |